United Therapeutics (UTHR) PT, Estimate Raised at BMO Capital
BMO Capital analyst Jim Birchenough reiterated an Outperform rating and boosted his price target on United Therapeutics Corp. (NASDAQ: UTHR) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
